|
AE with an outcome of lab test abnormal
|
|
|
|
| Influenza serology positive |
32 |
28.46 |
715.61 |
| Chest X-ray abnormal |
24 |
4.00 |
51.89 |
| Blood creatine phosphokinase increased |
19 |
3.96 |
40.33 |
| Blood glucose increased |
18 |
2.25 |
11.95 |
| Urine analysis abnormal |
15 |
2.78 |
16.43 |
| Computerised tomogram abnormal |
13 |
2.23 |
8.44 |
| Nuclear magnetic resonance imaging brain abnormal |
13 |
2.74 |
13.77 |
| Electrocardiogram abnormal |
11 |
2.36 |
8.27 |
| Neutrophil percentage increased |
11 |
3.00 |
14.13 |
| Urine ketone body present |
10 |
7.11 |
49.64 |
| Lymphocyte percentage decreased |
9 |
3.13 |
12.51 |
|
behavior and neurological AE
|
|
|
|
| Headache |
383 |
2.22 |
257.06 |
| Fatigue |
159 |
2.16 |
97.17 |
| Abdominal pain upper |
54 |
3.49 |
92.50 |
| Ear pain |
22 |
3.01 |
28.48 |
| Migraine |
21 |
2.54 |
18.85 |
| Abdominal discomfort |
15 |
3.38 |
24.20 |
| Burning sensation |
15 |
2.25 |
9.97 |
| Sinus headache |
14 |
18.72 |
208.53 |
| VIIth nerve paralysis |
11 |
11.08 |
93.29 |
| Facial paresis |
9 |
5.37 |
30.53 |
| Ataxia |
8 |
3.50 |
13.72 |
|
cardiovascular disorder AE
|
|
|
|
| Epistaxis |
71 |
14.71 |
823.81 |
| Pericarditis |
9 |
3.97 |
19.16 |
|
digestive system AE
|
|
|
|
| Retching |
12 |
3.27 |
18.19 |
| Dry throat |
10 |
10.32 |
78.17 |
|
gustatory system AE
|
|
|
|
| Throat irritation |
17 |
3.05 |
22.55 |
|
errored drug administration
|
|
|
|
| Expired drug administered |
503 |
90.04 |
28507.94 |
| Inappropriate schedule of drug administration |
169 |
4.15 |
390.47 |
|
eye disorder AE
|
|
|
|
| Photophobia |
17 |
2.66 |
16.90 |
| Eye irritation |
10 |
3.41 |
16.37 |
| Visual impairment |
9 |
3.05 |
11.92 |
|
homeostasis AE
|
|
|
|
| Swelling face |
44 |
2.51 |
38.58 |
| Eyelid edema |
13 |
2.03 |
6.49 |
|
immune system disorder
|
|
|
|
| Immunization reaction |
9 |
2.43 |
7.30 |
|
infection adverse event
|
|
|
|
| Croup infectious |
11 |
9.58 |
78.80 |
|
injury and procedural complication AE
|
|
|
|
| Pregnancy test positive |
10 |
3.21 |
14.60 |
|
medical intervention
|
|
|
|
| Drug exposure during pregnancy |
77 |
3.90 |
159.92 |
| Accidental exposure |
30 |
20.56 |
490.83 |
| Vaccination error |
13 |
30.19 |
306.90 |
| Underdose |
11 |
11.64 |
98.65 |
| Drug administration error |
9 |
5.81 |
34.07 |
|
muscle disorder AE
|
|
|
|
| Bronchospasm |
8 |
4.60 |
21.52 |
|
respiratory system AE
|
|
|
|
| Rhinorrhea |
210 |
9.47 |
1493.03 |
| Nasal congestion |
177 |
11.64 |
1593.58 |
| Sneezing |
53 |
10.78 |
436.15 |
| Pneumonia |
43 |
2.01 |
20.90 |
| Sinusitis |
43 |
5.92 |
167.24 |
| Asthma |
35 |
2.07 |
18.45 |
| Respiratory tract congestion |
32 |
7.68 |
175.14 |
| Upper respiratory tract infection |
25 |
2.22 |
16.05 |
| Nasopharyngitis |
25 |
4.08 |
55.69 |
| Bronchitis |
23 |
2.81 |
25.84 |
| Sinus congestion |
13 |
8.49 |
80.57 |
| Nasal discomfort |
12 |
47.77 |
422.18 |
| Stridor |
10 |
3.82 |
19.93 |
| Postnasal drip |
10 |
20.90 |
166.27 |
| Lobar pneumonia |
10 |
15.77 |
124.77 |
|
skin adverse event
|
|
|
|
| Pruritus generalized |
15 |
2.94 |
18.45 |
| Rash pustular |
15 |
2.19 |
9.29 |
| Henoch-Schonlein purpura |
15 |
8.20 |
89.03 |
|
social behavior AE
|
|
|
|
| Activities of daily living impaired |
23 |
2.36 |
17.29 |
| Impaired work ability |
8 |
3.96 |
16.94 |
